Cargando…

Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B

Fraxetin is a coumarin scaffold compound extracted from Fraxinus rhynchophylla. It has antioxidant, anti-inflammatory, hepatoprotective, and antifibrotic effects. Furthermore, fraxetin has anticancer effects in breast and lung cancer. We aimed to evaluate whether fraxetin has anticancer activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jisoo, Ham, Jiyeon, Hong, Taeyeon, Song, Gwonhwa, Lim, Whasun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830088/
https://www.ncbi.nlm.nih.gov/pubmed/33477262
http://dx.doi.org/10.3390/pharmaceutics13010112
_version_ 1783641326342897664
author Song, Jisoo
Ham, Jiyeon
Hong, Taeyeon
Song, Gwonhwa
Lim, Whasun
author_facet Song, Jisoo
Ham, Jiyeon
Hong, Taeyeon
Song, Gwonhwa
Lim, Whasun
author_sort Song, Jisoo
collection PubMed
description Fraxetin is a coumarin scaffold compound extracted from Fraxinus rhynchophylla. It has antioxidant, anti-inflammatory, hepatoprotective, and antifibrotic effects. Furthermore, fraxetin has anticancer effects in breast and lung cancer. We aimed to evaluate whether fraxetin has anticancer activity in hepatocellular carcinoma (HCC) cells and its underlying mechanism. We demonstrated the anticancer effects of fraxetin in the HCC cell lines Huh7 and Hep3B. We confirmed that fraxetin inhibited cell proliferation (42% ± 10% Huh7; 52% ± 7% Hep3B) by arresting the cell cycle and inducing apoptosis in both cell lines. Moreover, fraxetin increased reactive oxygen species production (221% ± 55% Huh7; 460% ± 73% Hep3B), depolarized the mitochondrial membranes (ΔΨm) (345% ± 160% Huh7; 462% ± 140% Hep3B), and disrupted calcium homeostasis in both HCC cell lines. Chelating calcium ions with BAPTA-AM restored proliferation in fraxetin-treated Huh7 cells but not in Hep3B cells. Fraxetin did not affect the phosphorylation of extracellular-signal-regulated kinase 1/2, whereas it decreased JNK and phosphoinositide 3-kinase signaling. Furthermore, fraxetin and mitogen-activated protein kinase pharmacological inhibitors had synergistic antiproliferative effects on HCC cells. Although our study was limited to in vitro data that require validation, we suggest that fraxetin is a potential therapeutic agent against HCC progression.
format Online
Article
Text
id pubmed-7830088
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78300882021-01-26 Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B Song, Jisoo Ham, Jiyeon Hong, Taeyeon Song, Gwonhwa Lim, Whasun Pharmaceutics Article Fraxetin is a coumarin scaffold compound extracted from Fraxinus rhynchophylla. It has antioxidant, anti-inflammatory, hepatoprotective, and antifibrotic effects. Furthermore, fraxetin has anticancer effects in breast and lung cancer. We aimed to evaluate whether fraxetin has anticancer activity in hepatocellular carcinoma (HCC) cells and its underlying mechanism. We demonstrated the anticancer effects of fraxetin in the HCC cell lines Huh7 and Hep3B. We confirmed that fraxetin inhibited cell proliferation (42% ± 10% Huh7; 52% ± 7% Hep3B) by arresting the cell cycle and inducing apoptosis in both cell lines. Moreover, fraxetin increased reactive oxygen species production (221% ± 55% Huh7; 460% ± 73% Hep3B), depolarized the mitochondrial membranes (ΔΨm) (345% ± 160% Huh7; 462% ± 140% Hep3B), and disrupted calcium homeostasis in both HCC cell lines. Chelating calcium ions with BAPTA-AM restored proliferation in fraxetin-treated Huh7 cells but not in Hep3B cells. Fraxetin did not affect the phosphorylation of extracellular-signal-regulated kinase 1/2, whereas it decreased JNK and phosphoinositide 3-kinase signaling. Furthermore, fraxetin and mitogen-activated protein kinase pharmacological inhibitors had synergistic antiproliferative effects on HCC cells. Although our study was limited to in vitro data that require validation, we suggest that fraxetin is a potential therapeutic agent against HCC progression. MDPI 2021-01-17 /pmc/articles/PMC7830088/ /pubmed/33477262 http://dx.doi.org/10.3390/pharmaceutics13010112 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Song, Jisoo
Ham, Jiyeon
Hong, Taeyeon
Song, Gwonhwa
Lim, Whasun
Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B
title Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B
title_full Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B
title_fullStr Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B
title_full_unstemmed Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B
title_short Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B
title_sort fraxetin suppresses cell proliferation and induces apoptosis through mitochondria dysfunction in human hepatocellular carcinoma cell lines huh7 and hep3b
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830088/
https://www.ncbi.nlm.nih.gov/pubmed/33477262
http://dx.doi.org/10.3390/pharmaceutics13010112
work_keys_str_mv AT songjisoo fraxetinsuppressescellproliferationandinducesapoptosisthroughmitochondriadysfunctioninhumanhepatocellularcarcinomacelllineshuh7andhep3b
AT hamjiyeon fraxetinsuppressescellproliferationandinducesapoptosisthroughmitochondriadysfunctioninhumanhepatocellularcarcinomacelllineshuh7andhep3b
AT hongtaeyeon fraxetinsuppressescellproliferationandinducesapoptosisthroughmitochondriadysfunctioninhumanhepatocellularcarcinomacelllineshuh7andhep3b
AT songgwonhwa fraxetinsuppressescellproliferationandinducesapoptosisthroughmitochondriadysfunctioninhumanhepatocellularcarcinomacelllineshuh7andhep3b
AT limwhasun fraxetinsuppressescellproliferationandinducesapoptosisthroughmitochondriadysfunctioninhumanhepatocellularcarcinomacelllineshuh7andhep3b